BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31166000)

  • 1. Exercise Recommendations for Women with Polycystic Ovary Syndrome: Is the Evidence Enough?
    Stepto NK; Patten RK; Tassone EC; Misso ML; Brennan L; Boyle J; Boyle RA; Harrison CL; Hirschberg AL; Marsh K; Moreno-Asso A; Redman L; Thondan M; Wijeyaratne C; Teede HJ; Moran LJ
    Sports Med; 2019 Aug; 49(8):1143-1157. PubMed ID: 31166000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
    Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):251-268. PubMed ID: 30024653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Eur J Endocrinol; 2023 Aug; 189(2):G43-G64. PubMed ID: 37580861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.
    Costello MF; Misso ML; Balen A; Boyle J; Devoto L; Garad RM; Hart R; Johnson L; Jordan C; Legro RS; Norman RJ; Mocanu E; Qiao J; Rodgers RJ; Rombauts L; Tassone EC; Thangaratinam S; Vanky E; Teede HJ;
    Hum Reprod Open; 2019; 2019(1):hoy021. PubMed ID: 31486807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management.
    Moran LJ; Tassone EC; Boyle J; Brennan L; Harrison CL; Hirschberg AL; Lim S; Marsh K; Misso ML; Redman L; Thondan M; Wijeyaratne C; Garad R; Stepto NK; Teede HJ
    Obes Rev; 2020 Oct; 21(10):e13046. PubMed ID: 32452622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-Scale Evidence-Based Guideline Development Engaging the International PCOS Community.
    Misso ML; Tassone EC; Costello MF; Dokras A; Laven J; Moran LJ; Teede HJ;
    Semin Reprod Med; 2018 Jan; 36(1):28-34. PubMed ID: 30189448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Misso ML; Boyle JA; Garad RM; McAllister V; Downes L; Gibson M; Hart RJ; Rombauts L; Moran L; Dokras A; Laven J; Piltonen T; Rodgers RJ; Thondan M; Costello MF; Norman RJ;
    Med J Aust; 2018 Oct; 209(S7):S3-S8. PubMed ID: 30453865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study.
    Al Wattar BH; Fisher M; Bevington L; Talaulikar V; Davies M; Conway G; Yasmin E
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2436-2446. PubMed ID: 33839790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent polycystic ovary syndrome according to the international evidence-based guideline.
    Peña AS; Witchel SF; Hoeger KM; Oberfield SE; Vogiatzi MG; Misso M; Garad R; Dabadghao P; Teede H
    BMC Med; 2020 Mar; 18(1):72. PubMed ID: 32204714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome.
    Pundir J; Charles D; Sabatini L; Hiam D; Jitpiriyaroj S; Teede H; Coomarasamy A; Moran L; Thangaratinam S
    Hum Reprod Update; 2019 Mar; 25(2):243-256. PubMed ID: 30608609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle interventions and quality of life for women with polycystic ovary syndrome: A systematic review and meta-analysis protocol.
    de Lima Nunes R; Dos Santos IK; Cobucci RN; Pichini GS; Soares GM; de Oliveira Maranhão TM; Dantas PMS
    Medicine (Baltimore); 2019 Dec; 98(50):e18323. PubMed ID: 31852122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary and Physical Activity Behaviors in Women with Polycystic Ovary Syndrome per the New International Evidence-Based Guideline.
    Lin AW; Kazemi M; Jarrett BY; Vanden Brink H; Hoeger KM; Spandorfer SD; Lujan ME
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.